2015 American Transplant Congress
The Penalty Faced By Native Americans in Kidney Transplantation: Decreased Access and Reduced Long-Term Survival
Background: Diabetes and ESRD disproportionately affect NAs (Native Americans), yet waitlisted NAs have lower rates of kidney transplantation than other racial/ethnic groups and worse longer…2015 American Transplant Congress
Dual Kidney Transplantation – Utilising Marginal Kidneys
Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom.
Background: With the increasing shortage of donor kidneys a constant review of organ quality and utilisation is required. Getting any positive result from a potential…2015 American Transplant Congress
Survival Outcomes of Kidney Transplant Recipients from Expanded Criteria Donors: A Systematic Review and Meta-Analysis
Background: In 2002, UNOS proposed the use of Expanded Criteria Donors (ECD=brain dead donor > 60 years, or 50-59 years with two criteria: CVA as…2015 American Transplant Congress
Belatacept Treatment Through Home Infusion as a Safe and Reasonable Alternative to Intitution-Based Treatment: A Retrospective Analysis of Medical Records
1Bristol-Myers Squibb Company, Princeton, NJ; 2BiologicTx, Totowa, NJ.
Purpose: Belatacept is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant in combination with basiliximab…2015 American Transplant Congress
Efficacy of Rituximab Sparing Protocol for ABO Incompatible Renal Transplant in Patients With Low Titers
[Introduction]Acute antibody mediated rejection (AMR) has been a major problem in ABO-incompatible kidney transplantation (ABOi-KTx), and currently mycophenolate mofetil and rituximab have been used to…2015 American Transplant Congress
The Impact of CDC High Risk Donors on Patient and Graft Survival After Liver Transplantation
We hypothesized that CDC high risk donors (HRD) might be younger than non-HRD and have other characteristics associated with favorable outcomes after liver transplant (LT).…2015 American Transplant Congress
Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report
1Surgery, Porter Adventist Hospital, Denver, CO; 2Medicine, Porter Adventist Hospital, Denver, CO.
INTRODUCTION: Discrepancy between demand (end stage organ disease) and supply (organs) remains one of the limiting factors in solid organ transplantation and underlies the dynamics…2015 American Transplant Congress
Vitamin D Deficiency in Liver Transplant Recipients: Prevalence, Risk Factors, and Outcomes
Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Vitamin D is known to be immunomodulatory, and its deficiency is associated with multiple chronic health problems in the general population. The objective of this…2015 American Transplant Congress
Age Should Not Be Considered a Contraindication for Living Kidney Donation
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The increasing numbers of patients with ESRD on the transplant waiting list has been the main driving force for expanding the donor pool. Acceptance of…2015 American Transplant Congress
The Effect of Changing Candidate Demographics on Living Donor Kidney Transplant Rates
Medicine, University of Virginia, Charlottesville, VA.
Living donor (LD) rates continue to decline despite a growing list of candidates for renal transplant in the US. While there are many factors driving…
- « Previous Page
- 1
- …
- 144
- 145
- 146
- 147
- 148
- …
- 170
- Next Page »